Browse the detailed record of transactions filed by 구병주, Independent Director. Insider active across 2 companies, notably 엔지켐생명과학. Aggregated, 17,943 disclosures have been logged. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Koo Byeong-joo is an Independent Board Member at Enzychem Lifesciences. In this role, he participates in strategic decision-making and governance of the company. With significant experience in the industry, Koo Byeong-joo contributes to strategic direction and oversight of operations. His expertise is essential for ensuring compliance and performance of the company.